BIOLQ (Biolase) Research & Development: $4.92 Mil (TTM As of Sep. 2024)

Biolase BIOLQ -99.00% 16 Research & Development is $4.92 Mil as of Sep. 2024. GuruFocus rates BIOLQ with a GF Score™ of 16/100.

Research & Development is the aggregate amount of research and development expenses during the year. Biolase's Research & Development for the three months ended in Sep. 2024 was $0.92 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 was $4.92 Mil.

Biolase (OTCPK:BIOLQ) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Biolase Research & Development Related Terms

Biolase Research & Development Historical Data

* Premium members only.

The historical data trend for Biolase's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biolase Research & Development Chart

Biolase Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Research & Development

Get a 7-Day Free Trial

4.77

3.70

6.05

7.27

6.00

Biolase Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Research & Development	Get a 7-Day Free Trial															1.36	1.65	1.28	1.07	0.92

16GF Score

Biolase Inc BIOLQ

Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Biolase Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $4.92 Mil.

Frequently Asked Questions Learn more about Research & Development →

What does a Research & Development of $4.92 Mil mean?

Biolase (BIOLQ) has a Research & Development of $4.92 Mil as of Sep. 2024. Research and development expense is the total cost for research and development activities. View historical data on Biolase and its competitors.

Is Biolase's Research & Development too high?

Biolase's current Research & Development is $4.92 Mil. Overall, Biolase has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.

How does Biolase's Research & Development compare to OPGN and AFIB?

Biolase's Research & Development of $4.92 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Research & Development for a Medical Devices & Instruments company?

A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Research & Development mean?

A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Biolase and its competitors. Biolase's current Research & Development is $4.92 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Biolase stock overvalued right now?

Biolase (BIOLQ) has a current Research & Development of $4.92 Mil. The current Research & Development is $4.92 Mil. Biolase's overall GF Score™ is 16/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Research & Development calculated?

Research & Development is calculated from a company's financial statements. For Biolase (BIOLQ), the current Research & Development is $4.92 Mil as of Sep. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biolase Business Description

Industry Healthcare Medical Devices & Instruments

Comparable Companies OPGN AFIB ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM XAMS:PHIA STE PODD ZBH SHSE:688271 XSWX:SOON LSE:SN.TSE:7733 ASX:COH PEN

Address 27042 Towne Centre Drive, Suite 270, Lake Forest, CA, USA, 92610

Website https://www.biolase.com

Biolase Inc is a United States-based provider of laser systems for the dental industry. It develops, manufactures, markets, and sells laser systems in dentistry and medicine. The company offers two categories of laser system products: Waterlase (all-tissue) systems and Diode (soft-tissue) systems which allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The majority of the company's revenue comes from the United States.

16GF Score

Get the complete analysis for BIOLQ

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00

Price

View BIOLQ Analysis

See Research & Development data for all stocks →